Evolution: How vertebrates got their bite

A newly discovered enhancer region may have allowed vertebrates to evolve the ability to open and close their jaws.
  1. Thomas F Schilling  Is a corresponding author
  2. Pierre Le Pabic
  1. Department of Developmental and Cell Biology, University of California, Irvine, United States
  2. Department of Biology and Marine Biology, University of North Carolina, United States

Most vertebrates, including humans, evolved from jawless fish which roamed the oceans 420–390 million years ago (Forey and Janvier, 1993). Acquiring jaws allowed our ancestors to bite and chew, expanding the range of food they could eat and where they could live. Understanding how this mouth structure arose is therefore a central question in evolution (Miyashita, 2016).

Studies in lampreys and hagfish, the only species of jawless fish that still exist today, suggest that the jaw evolved from a pre-existing skeletal system surrounding the mouth and throat that was used for filtering food and breathing. A key step in this process was the acquisition of a mobile joint, essentially a skeletal hinge that can open and close the mouth. For this to happen, cells within the jaw skeleton – most likely cartilage cells – had to alter their gene expression to become more flexible. Such changes often involve enhancers, regions of DNA that control when a nearby gene is expressed, and in which part of the body.

Very few enhancer sequences have been preserved between species over long evolutionary periods (Long et al., 2016), and these often control processes related to development (Pennacchio et al., 2006; Bejerano et al., 2004; Lettice et al., 2003; Kvon et al., 2016; Leal and Cohn, 2016; Letelier et al., 2018). Now, in eLife, Tatjana Haitina and colleagues from Uppsala University – including Jake Leyhr as first author – report the discovery of a widely conserved enhancer named Joint Regulatory Sequence 1 (JRS1) that is critical for the development of the jaw joint and, potentially, the early evolution of the jaw (Leyhr et al., 2022).

The team spotted JRS1 by comparing the genomes of multiple species and noticing a sequence present in most jawed vertebrates, but missing in lampreys and hagfish (Figure 1). Experiments in zebrafish revealed that this enhancer drives the expression of a gene called nkx3.2, which encodes a transcription factor essential for jaw joint development. This gene is specifically expressed in the jaw joint of embryos, where it regulates the activity of other genes needed to form the hinge that opens and closes the mouth (Miller et al., 2003; Waldmann et al., 2021; Smeeton et al., 2021).

The role of the enhancer JRS1 in evolution and development.

Most species in the family of jawed vertebrates (Gnathostomata) evolved from jawless fish (Agnatha). Leyhr et al. have identified an enhancer sequence – which they call JRS1 (short for Jaw joint Regulatory Sequence; left) – that is present in the genomes of multiple species of Gnathostomata, but is absent from the two living Agnathan species (lampreys and hagfish). This genetic sequence (red hexagon) drives expression of the gene nkx3.2 (blue arrow) in the jaw joint (black arrow) of zebrafish Danio rerio embryos (top right). Deleting JRS1 (black cross) eliminates nxk3.2 expression, leading to jaw joint fusion and the mouth no longer being able to open and close (bottom right). Images of Gnathostomata and Agnatha are based on drawings by Goodrich, 1930.

To investigate where JRS1 drives expression of nxk3.2 across jawed vertebrates, Leyhr et al. manipulated the genome of zebrafish embryos by placing the coding sequence for a fluorescent reporter under the control of JRS1 sequences from other species. The JRS1 region of all the vertebrates studied, including humans, induced expression in the jaw joint and surrounding cartilage, despite the enhancer sequence varying slightly between species. Further experiments provided additional details about the role of JRS1 in zebrafish, showing that zebrafish embryos genetically modified to lack a functional JRS1 enhancer expressed less nxk3.2, which caused their upper and lower jaw to transiently fuse (Figure 1).

Lampreys lack the JRS1 sequence and associated expression of nxk3.2 in their first pharyngeal arch, which will go on to form the cartilage, bone and other structures of the jaw. However, other genes involved in jaw patterning are still expressed during lamprey development, suggesting that JRS1 appeared late in jaw joint evolution (Cerny et al., 2010). In particular, lamprey embryos activate several genes that control the identity of the upper and lower jaw in other vertebrates, the significance of which is an exciting subject for future studies.

There is growing recognition of how enhancers impact development and disease, but very few have been shown to have essential roles in vivo, or to contribute to morphological evolution. The work of Leyhr et al. has important implications for the basic understanding of jaw evolution, and could potentially help researchers identify the genetic causes underlying craniofacial defects.


Article and author information

Author details

  1. Thomas F Schilling

    Thomas F Schilling is in the Department of Developmental and Cell Biology, University of California, Irvine, Irvine, United States

    For correspondence
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1798-8695
  2. Pierre Le Pabic

    Pierre Le Pabic is in the Department of Biology and Marine Biology, University of North Carolina, Wilmington, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7384-6814

Publication history

  1. Version of Record published: November 15, 2022 (version 1)


© 2022, Schilling and Le Pabic

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 2,104
    Page views
  • 124
  • 1

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Thomas F Schilling
  2. Pierre Le Pabic
Evolution: How vertebrates got their bite
eLife 11:e84118.

Further reading

    1. Developmental Biology
    Nicolas G Brukman, Clari Valansi, Benjamin Podbilewicz
    Research Article Updated

    The fusion of mammalian gametes requires the interaction between IZUMO1 on the sperm and JUNO on the oocyte. We have recently shown that ectopic expression of mouse IZUMO1 induces cell-cell fusion and that sperm can fuse to fibroblasts expressing JUNO. Here, we found that the incubation of mouse sperm with hamster fibroblasts or human epithelial cells in culture induces the fusion between these somatic cells and the formation of syncytia, a pattern previously observed with some animal viruses. This sperm-induced cell-cell fusion requires a species-matching JUNO on both fusing cells, can be blocked by an antibody against IZUMO1, and does not rely on the synthesis of new proteins. The fusion is dependent on the sperm’s fusogenic capacity, making this a reliable, fast, and simple method for predicting sperm function during the diagnosis of male infertility.

    1. Biochemistry and Chemical Biology
    2. Developmental Biology
    Sima Stroganov, Talia Harris ... Michal Neeman
    Research Article Updated


    Fetal growth restriction (FGR) is a pregnancy complication in which a newborn fails to achieve its growth potential, increasing the risk of perinatal morbidity and mortality. Chronic maternal gestational hypoxia, as well as placental insufficiency are associated with increased FGR incidence; however, the molecular mechanisms underlying FGR remain unknown.


    Pregnant mice were subjected to acute or chronic hypoxia (12.5% O2) resulting in reduced fetal weight. Placenta oxygen transport was assessed by blood oxygenation level dependent (BOLD) contrast magnetic resonance imaging (MRI). The placentae were analyzed via immunohistochemistry and in situ hybridization. Human placentae were selected from FGR and matched controls and analyzed by immunohistochemistry (IHC). Maternal and cord sera were analyzed by mass spectrometry.


    We show that murine acute and chronic gestational hypoxia recapitulates FGR phenotype and affects placental structure and morphology. Gestational hypoxia decreased labyrinth area, increased the incidence of red blood cells (RBCs) in the labyrinth while expanding the placental spiral arteries (SpA) diameter. Hypoxic placentae exhibited higher hemoglobin-oxygen affinity compared to the control. Placental abundance of Bisphosphoglycerate mutase (BPGM) was upregulated in the syncytiotrophoblast and spiral artery trophoblast cells (SpA TGCs) in the murine gestational hypoxia groups compared to the control. Hif1α levels were higher in the acute hypoxia group compared to the control. In contrast, human FGR placentae exhibited reduced BPGM levels in the syncytiotrophoblast layer compared to placentae from healthy uncomplicated pregnancies. Levels of 2,3 BPG, the product of BPGM, were lower in cord serum of human FGR placentae compared to control. Polar expression of BPGM was found in both human and mouse placentae syncytiotrophoblast, with higher expression facing the maternal circulation. Moreover, in the murine SpA TGCs expression of BPGM was concentrated exclusively in the apical cell side, in direct proximity to the maternal circulation.


    This study suggests a possible involvement of placental BPGM in maternal-fetal oxygen transfer, and in the pathophysiology of FGR.


    This work was supported by the Weizmann Krenter Foundation and the Weizmann – Ichilov (Tel Aviv Sourasky Medical Center) Collaborative Grant in Biomedical Research, by the Minerva Foundation, by the ISF KillCorona grant 3777/19.